From January to April, operating margins were up 23% year over year while operating EBITDA margin jumped 14%. Across the U.S., operating margins were up everywhere but the Great Plains region.
“April data show a relatively strong month, with margins and other key performance indicators, including outpatient revenue and OR minutes, increasing,” the report authors wrote. “Average lengths of stay decreased, reflecting a return to more normal care patterns and the establishment of stronger post-acute care transitions.”
Here is the regional and hospital size breakdown of the operating margin data:
National averages
Operating margin
Month over month: 7%
Year over year: 31%
Year to date: 23%
Operating EBITDA margin
Month over month: 4%
Year over year: 22%
Year to date: 14%
West
Operating margin
Month over month: 6%
Year over year: 51%
Year to date: 33%
Operating EBITDA margin
Month over month: 11%
Year over year: 35%
Year to date: 18%
Midwest
Operating margin
Month over month: 15%
Year over year: 29%
Year to date: 17%
Operating EBITDA margin
Month over month: 11%
Year over year: 22%
Year to date: 15%
South
Operating margin
Month over month: 1%
Year over year: 37%
Year to date: 30%
Operating EBITDA margin
Month over month: 0%
Year over year: 29%
Year to date: 16%
Northeast / Mid-Atlantic
Operating margin
Month over month: 7%
Year over year: 34%
Year to date: 21%
Operating EBITDA margin
Month over month: 6%
Year over year: 20%
Year to date: 9%
Great Plains
Operating margin
Month over month: 15%
Year over year: -3%
Year to date: -6%
Operating EBITDA margin
Month over month: 16%
Year over year: -2%
Year to date: -4%
200-299 beds
Operating margin
Month over month: 1.3%
Year over year: 25.4%
Year to date: 28.5%
Operating EBITDA margin
Month over month: 0.4%
Year over year: 19.1%
Year to date: 18.6%
300-499 beds
Operating margin
Month over month: 10.8%
Year over year: 35.5%
Year to date: 33.2%
Operating EBITDA margin
Month over month: 4.1%
Year over year: 25.2%
Year to date: 16.1%
500+ beds
Operating margin
Month over month: -1.9%
Year over year: 60.6%
Year to date: 30.1%
Operating EBITDA margin
Month over month: 1.7%
Year over year: 34.8%
Year to date: 12.8%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
